Goldman Myla Lai - 12 Jun 2023 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Myla Lai-Goldman, by Brian McKelligon, as Attorney-in-Fact
Issuer symbol
AKYA
Transactions as of
12 Jun 2023
Transactions value $
$100,000
Form type
4
Filing time
12 Jun 2023, 18:18:10
Previous filing
05 Jun 2023
Next filing
25 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Purchase $100K +20K $5.00 20K 12 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.